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Abstract
The link between metals, Alzheimer’s disease (AD) and its implicated protein, amyloid-b (Ab), is complex and highly studied.
AD is believed to occur as a result of the misfolding and aggregation of Ab. The dyshomeostasis of metal ions and their
propensity to interact with Ab has also been implicated in AD. In this work, we use single molecule atomic force
spectroscopy to measure the rupture force required to dissociate two Ab (1–42) peptides in the presence of copper ions,
Cu2+. In addition, we use atomic force microscopy to resolve the aggregation of Ab formed. Previous research has shown
that metal ions decrease the lag time associated with Ab aggregation. We show that with the addition of copper ions the
unbinding force increases notably. This suggests that the reduction of lag time associated with Ab aggregation occurs on a
single molecule level as a result of an increase in binding forces during the very initial interactions between two Ab
peptides. We attribute these results to copper ions acting as a bridge between the two peptide molecules, increasing the
stability of the peptide-peptide complex.
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Introduction
Amyloid-b (Ab) is a 35–43 long amino acid peptide implicated
in the neurodegenerative protein misfolding disease known as
Alzheimer’s disease (AD) [1]. There are about twenty seven
protein misfolding diseases identified including Parkinson’s,
Huntington’s, type II diabetes and protein alveolar proteinosis.
Each one of the protein misfolding diseases has an associated
protein that misfolds into a pathological state. Normally, Ab exists
primarily as a a-helical or random coil structure, but can misfold
into a b-sheet structure that is prone to aggregate into toxic
amyloid oligomers and insoluble amyloid fibrils [2,3,4,5]. The
mechanism for this misfolding has not yet been identified. The
initial misfolding of amyloid-b onto itself occurs through the
folding of amino acid sequences 16–23 onto 28–35 to form a b-
sheet structure [5]. It is now accepted that the oligomers, which
may form along a distinct pathway, are more neurotoxic than the
relatively inert amyloid fibrils [6,7,8,9]. Despite extensive research,
the mechanism of action of Ab is not clearly understood.
The factors affecting AD are diverse and their interrelatedness
remains elusive. Genetic factors [10], metals [5,11], and vascular
deficiencies [12] have been found to be associated with AD. Also,
the Alzheimer’s afflicted brain has been shown to suffer from
severe oxidative stress [13,14] and inflammation [15]. In post-
mortem brains of AD patients, amyloid plaques were laden with
trace metals such as copper, zinc, and iron at concentrations up to
400 mM, 1 mM, and 1 mM, respectively [16]. Extensive research
has been conducted on the role of metal ions in the formation of
reactive oxygen species (ROS), and amyloid-metal complexes that
increase amyloid toxicity by ultimately promoting apoptosis
[17,18,19,20,21,22].
Ab aggregation begins with a lag phase at which point the
peptide progressively aggregates to form nucleation seeds [23].
The addition of metal ions has been shown to reduce the lag phase
associated with Ab aggregation [24]. Ab has been shown to bind
metal ions, such as copper, zinc, and aluminum, yielding amyloid-
metal complexes with varying effects [16,25,26,27]. The binding
of Ab to copper allows the peptide to insert into lipid membranes
more readily [28], while aluminum-Ab complexes have been
shown to disrupt lipid membranes [29].
The binding site of copper is believed to lie within the N-
terminal portion of the peptide. Specifically, there is a salt bridge
formed utilizing metals, such as zinc and copper, predominantly
through a His(13)-metal-His(14) conformation as well as bridges
with His(6) [26,30,31].
Previous research has shown that copper binds to these His co-
ordination sites with greater affinity than zinc [32] and signifi-
cantly stabilizes Ab aggregates [31]. The binding of copper causes
Ab to become redox active, which significantly contributes to the
oxidative stress prevalent in AD [5,13,14]. The reduction of Cu2+-
amyloid complexes to Cu+-amyloid complexes has been shown to
produce hydrogen peroxide [33] that in turn leads to the
formation of pro-apoptotic lipid peroxidation products, such as
4-hydroxynonenal, which ultimately induces neuronal cell apop-
tosis [18,20]. Thus, the binding of copper to Ab not only increases
neurotoxicity, but it has also been demonstrated to have kinetic
and thermodynamic implications [34].
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Single molecule atomic force spectroscopy (AFS) in combination
with atomic force microscopy (AFM), is a powerful approach to
study the effect of metals on amyloid aggregation and can shed
light on the very initial step of Ab aggregation as well as follow the
progression of this process with time. Single molecule AFS is an
AFM-based technique used to extract information from the
interaction of two molecules. Typically, a protein is bound to a
substrate and another protein to the tip of an AFM cantilever. The
tip is brought in close proximity to the surface and the two
molecules are allowed to bind. The tip is then retracted and the
peptide-peptide bond ruptures. The AFM apparatus quantitatively
measures the rupture force, and this force is recorded for statistical
analysis [35,36]. The application of single molecule atomic force
spectroscopy to study protein misfolding diseases has been
reviewed [37]. In this work, we study the effect of copper ions
on the peptide-peptide rupture force of the Ab (1–42) peptide. We
show that when copper ions are added to the Ab force
spectroscopy environment, the rupture force increases dramati-
cally, which correlates with a higher rate of aggregation shown by
AFM imaging. This is the first single-molecule study which shows
that Cu2+ increases the force of interaction between two single Ab
peptides; thus, affecting further aggregation.
Experimental Procedures
We used a widely accepted method of binding proteins through
N-terminus to PEG heterobifunctional cross linkers (35, 36), an
experimental setup as previously described [38]. Briefly, the
experimental procedures are outlined below.
Tip Surface and Mica Modification. Veeco MLCT Silicon
Nitride AFM cantilevers were cleaned by soaking in ethanol for 15
minutes, washed in ultrapure water and dried in a gentle stream of
nitrogen. The cantilever was then placed under UV light for 30
minutes. Mica was freshly cleaved. 3-aminopropyltriethoxy silane
(APS) was synthesized as previously described [39]. The structure
of APS was confirmed using NMR spectroscopy. The mica and
cantilever were then immersed in 167 mM APS for 30 minutes,
then rinsed with ultrapure water and dried under a gentle stream
of nitrogen. The mica and cantilever were then placed in a
3400 MW Polyethylene Glycol (PEG) solution (167 mM in
DMSO) (Laysan Bio, Alabaster GA) for 3 hours, than rinsed with
DMSO. The cantilever and mica were washed and stored in
HEPES buffer (50 mM HEPES, 150 mM NaCl, pH 7.4). We
specifically chose HEPES buffer because of the absence of metal
ions.
Ab (1–42) Preparation and Surface Binding. Cys-Ab (1–
42) was purchased from Anaspec (Fremont, CA) and prepared in
DMSO at a concentration of 1 mg/mL. The Ab stock solution
was then diluted in HEPES buffer to a final concentration of
20 nM. An equal volume of 200 nM tris(2-carboxyethyl)phosphine
(TCEP) was added to the dilute peptide solution to prevent
aggregation. The Ab solution was stored for 15 minutes and then
centrifuged at 14000 RPM for 15 minutes to move monomeric
forms to the top of the solution to ensure primarily monomeric
forms of the peptide were used. The mica and cantilevers were
soaked in the dilute Ab solution for 30 minutes. The Ab was rinsed
with HEPES buffer, and the mica was treated for 10 minutes with
b-mercaptoethanol to react with any available maleimide groups
so as to prevent false rupture events. Both cantilever and mica
were washed three times with HEPES buffer, and stored in
HEPES buffer until use.
Atomic Force Spectroscopy. A JPK Nanowizard II atomic
force microscope was used for all measurements. Cantilever spring
constants were measured using Hutter’s thermal tune method
[40], which requires both the normal sensitivity and the thermal
resonance spectra. The sensitivity was obtained from the gradient
of the contact portion of a force-displacement plot acquired on a
mica surface. The thermal spectrum was obtained using the JPK
hardware. The voltage response of the cantilever deflection
measured using the photodiode was converted to units of force
by multiplying by the normal sensitivity and the spring constant.
Mica coated with Ab as described earlier was placed on the stage
in the liquid cell and immersed in HEPES buffer. A series of force
curves were taken with an approach and retract velocity of
400 nm/s. A dwell time of 0.5 seconds was set to allow peptide-
peptide binding events. For a single experiment approximately
1000 force curves were recorded, out of which approximately 10%
of these showed specific unbinding events. Each experiment was
repeated four times with a different cantilever and substrate. For
each repeat experiment at least 100 force curves were analyzed, a
similar binary distribution was observed and representative
experiments are presented. Solutions of Cu2+ (purchased from
Sigma-Aldrich) in HEPES buffer were prepared at a concentration
of 20 nM and were added to the liquid cell for applicable
experiments.
Force Curve Analysis. JPK data analysis software was used
to analyze force curves. A worm like chain (WLC) fit was obtained
for each force curve and rupture forces were obtained. Rupture
force histograms were fitted with a sum of two Gaussian
distributions, and minimized using the Levenberg-Marquardt
non-linear least squares fitting routine in Matlab. Errors quoted
for the most probable rupture force are evaluated as the standard
deviation of each distribution, divided by the square root of the
effective number of counts for each distribution (estimate of
standard error). The effective number of counts was approximated
by multiplying the total number of data points by the area fraction
of the given Gaussian distribution.
Amyloid Incubation for AFM Imaging. Ab (1–42) (pur-
chased from rPeptide, Bogarta, GA) was pre-treated according to
the Fezoui procedure [41] to ensure the monomeric form. The
peptide solutions were prepared by adding HEPES buffer and
either Cu2+ ions or an equal amount of buffer to produce the
copper and control samples, respectively. The final concentration
of amyloid-b (1–42) was 55 mM, and the final concentration of
Cu2+ was 5.5 mM, which yielded a 10:1 amyloid-Cu2+ molar ratio.
The solutions were incubated at room temperature for 1 hour,
6 hours and 24 hours. 50 mL aliquots were placed onto freshly
cleaved mica at the respective times for a 5 minute adsorption
period. Excess amyloid solution was then washed with milliQ
water and dried with a gentle stream of N2 gas.
AFM Imaging. The mica slides with adsorbed amyloid were
placed in a JPK Nanowizard II atomic force microscope and
imaged in air in Intermittent Contact mode using cantilevers
purchased from NanosensorsTM (Non-contact/TappingTM mode -
High resonance frequency; non-coated; tip radius ,10 nm). All
images were taken with a line rate of 0.5 Hz, and the gains were
adjusted to yield maximum image quality. 10610 mm and
565 mm images were taken, and subsequently analyzed using
JPK Data Processing Software. Each experiment was repeated at
least twice and at least 3 images for each sample.
Results
We used a combination of single molecule atomic force
spectroscopy and atomic force microscopy to probe the single
molecule interactions of Ab in the presence of Cu2+ ions. Statistical
analysis was completed on force curves to determine the most
probable rupture force and Gaussian curve width. Figure 1
illustrates a schematic of the force spectroscopy experimental set
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up. Notice that Ab has been bound to both the tip and substrate
through APS and a PEG linker, via a cys residue at the N-
terminus.
Figure 2 shows a series of histograms of rupture events. For our
control experiment without any copper added, we observed
double Gaussian peaks centered on 6661 pN and 13264 pN.
These figures are shown in Table 1. With the addition of copper, a
much higher mean rupture force was observed, with copper
yielding rupture forces with double Gaussian peaks at 8363 and
16465 pN and mean rupture force of 178.9 pN.
Figure 3 shows sample force curves obtained with and without
copper and occurring within both the higher and lower Gaussian
peaks shown in figure 2.
Figure 4 shows AFM images of amyloid aggregates formed in
solution with and without copper ions added for incubation times
of 1 hour, 6 hours and 24 hours. We observed oligomeric amyloid
species with a mean height of approximately 3.13 nm after an
hour of incubation without copper, as seen in Figure 4A. After
6 hours, the control experiment (Figure 4B), revealed the
formation of a mixture of oligomeric species, and short fibrils that
were approximately 4.5 nm in height. At 24 hours of incubation
(Figure 4C), Ab aggregated to dominantly fibrillar species with a
mean height of 7.2 nm. The observed fibrils at 24 hours were
significantly longer than those observed at 6 hours, extending up
to 3 mm. Figures 4D–4F are representative images of the various
structural conformations of the Ab aggregates in the presence of
one tenth Cu2+ molar concentrations under the respective times.
Large amorphous aggregates with a mean height of 9.3 nm were
formed after 6 hours, which coincided with the formation of the
short fibrils as found in the respective control. After 24 hours,
these unique aggregates remained the dominant species, and the
populous fibrils that were observed in the control were not present.
Discussion
In a recent report, Sarell and colleagues [24] attributed the
increase in aggregation of Ab with substoichiometric levels of Cu2+
to charge neutralization caused by the binding of copper ions to
the copper binding site at the histidine residues resulting in a
peptide more prone to self-association. In this work, we present for
the first time measurements of the initial single molecule
interaction between two Ab peptides in the presence of Cu2+
ions. We show that with the addition of copper, the unbinding
(rupture) force increases notably. The increase in unbinding force
is consistent with the findings of other groups showing a reduction
of lag time in amyloid aggregation when copper is added to the
system [34]. This suggests that the reduction of lag time associated
with Ab aggregation occurs on a single molecule level as a result of
the very initial dimerization interactions between the peptides.
Figure 1. Force Spectroscopy Setup. A schematic of experimental
setup of force spectroscopy experiment showing Ab bound to
substrate and tip via the PEG linker.
doi:10.1371/journal.pone.0059005.g001
Figure 2. Effect of Copper on Ab rupture force. Histograms show
the distribution of forces required to rupture the Ab-Ab complex
without copper (A) and with copper (B). Fits to the data are Gaussian
distributions, the peaks of which represent the most probable rupture
force.
doi:10.1371/journal.pone.0059005.g002
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The rate of aggregation of aggregation-prone proteins, such as
Ab (1–40) and a-synuclein, has been shown to be a function of the
mean rupture force between two peptides [42,43]. It has been
established that the acceleration of aggregation is the result of a
decrease in the lag time associated with amyloid nucleation [44].
Although the mechanisms involved during this lag time have
previously been unclear, it is believed that the lag time is a result of
the development of a significant amyloid nucleus onto which other
Table 1. Statistical Data of Force Spectroscopy Experiments.
Gaussian Peak 1±SE (pN) Gaussian Peak 2±SE (pN) Mean Rupture Force (pN) Experimental Yield (%)
Ab Control 6661 13264 125.2 14.3
Cu2+ added 8363 16465 178.9 14.2
doi:10.1371/journal.pone.0059005.t001
Figure 3. Representative force curves. Force curves showing rupture forces of an Ab dimer without (A) and with (B) copper added at a retraction
rate of 400 nm/s. Curves are shown as force vs. piezo z-displacement.
doi:10.1371/journal.pone.0059005.g003
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peptides can bind to. We suggest that a reduction in lag time may
occur as a result of the very initial nucleation process: the
dimerization of two Ab peptides.
The common theory of the aggregation of Ab involves the
oligomer cascade hypothesis [1]. According to the oligomer
cascade hypothesis, monomeric species form a dimeric nucleation
site. Additional monomers are added to this nucleus to progres-
sively form larger oligomers, protofibrils and finally, mature
amyloid fibrils [1]. This paradigm has recently come under review
and a serious argument can now be made that pathological
oligomers and inert fibrils may form along separate pathways
[7,38,45]. Necula and colleagues have suggested that several
different oligomeric species may form following the misfolding of
the Ab monomer [9]. Only one of these oligomers may eventually
form fibrils, with other oligomers remaining in the most stable
oligomeric state. He and colleagues [44] studied the amyloid
forming b-lactoglobulin protein and have suggested a bifurcation
of its amyloid pathway at the 16mer point, where the aggregate
may continue as an oligomer or begin to form a protofibril [44].
Based on our data, we propose that, for Ab, the divergence of this
pathway begins much earlier: at the initial dimerization of the two
Ab peptides, where the structure of the initial dimer varies and
determines the pathway followed. In our control experiments
without copper, we observe two distinct force peaks most likely
associated with different dimer configurations, possibly parallel
and anti-parallel for two amyloid peptides interacting with each
other at the self-recognition site as proposed by Tjernberg [46,47]
and illustrated in figures 5A and B. The anti-parallel dimer
configuration (Figure 5A) is the more stable of the two stabilized by
salt bridges at each end [48], and therefore, we assign this
configuration to the stronger force observed (peak two, Figure 2A).
The first weaker force (peak one, Figure 2A) more likely
corresponds to the parallel configuration (Figure 5B).
Our interpretation of the data collected is consistent with the
results of Pedersen and colleagues [49]. Pedersen used bulk
measurements of Ab aggregation under the influence of Cu2+ and
concluded that copper alters the aggregation pathway of Ab. The
interpretation of our data is consistent with Pedersen’s conclusions.
Our results build on this data and propose a structural model
which is consistent with the observations provided by our groups.
The addition of copper ions significantly increases the
unbinding forces of Ab peptides, at the same time the two distinct
peaks shift to a higher value (Figure 2B). It was also apparent that
though there is a shift in the two Gaussian peaks, the proportion of
the number of binding events in the first peak to the second peak
decreases when copper is added to the environment. Based on our
hypothesis that there are at least two different conformations of the
Ab dimer, we believe that the addition of copper increases the
probability of Ab to dimerize in a conformation correlating with
the second peak, corresponding to a larger binding force. Given
these differences in unbinding forces, we suggest that both the
parallel and anti-parallel dimer conformations become stabilized
by Cu2+ ions, which results in the shift of these peaks to higher
forces. Considering the possibility of Ab-Ab binding both with and
without Cu2+ ions, we suggest four possible complexes that can be
formed in this case: Ab-Ab parallel, Ab-Cu-Ab parallel, Ab-Ab
anti-parallel, Ab-Cu-Ab antiparallel. Our hypothesis is further
supported by recent theoretical work by Mousseau [50] and
Urbanc [51]. Using molecular dynamics simulations, both groups
independently demonstrated that Ab (1–42) can dimerize in
multiple conformations along multiple pathways. It stands to
reason that different dimer conformations have different unbind-
ing forces.
We considered alternative explanations to our hypothesis to
explain the presence of two most probable force peaks. We
considered that two distinct dimers are rupturing at the same time
yielding one much larger force. Based on the probability of a
binding and unbinding event, we applied the method proposed by
Akhremitchev [52] to determine the probability of two or more
peptides being located in the same area and rupturing simulta-
neously. For our highest yielding experiments, where the most
rupture events happened for a given number of approaches, we
calculate this probability to be p= 0.12. Consistent with previous
analysis methods, the force curves with the (p6n, n= number of
Figure 4. AFM images of amyloid-metal aggregates. AFM images of Ab incubated without copper for periods of 1 hr (A) 6 hr (B) and 24 hr (C),
and with copper at a 10:1 molar ratio for 1 hr (D), 6 hr (E), and 24 hr (F). The lateral scale bar is 1 mm.
doi:10.1371/journal.pone.0059005.g004
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force curves) highest rupture forces were discarded and not
included in the rupture force histograms. Over several thousand
collected force curves, we did indeed observe some double, and
even triple, binding events. However, given the inhomogeneity of
the length of the PEG linkers, these events were identified by two
force curves with the distance between them being a function of
the difference in PEG linkers rather than one large force curve.
Given our statistical observations, we conclude that any double
unbinding event masquerading as a single force curve is so
improbable as to be negligible, and certainly would not approach
the greater than 50% of force curves that occur at the higher force.
Our second alternative explanation for the presence of these
double force peaks is that instead of a monomeric peptide being
bound at the end of the PEG linker, aggregation has occurred
prior to attachment to the PEG linker and an amyloid oligomer
was in fact bound at the end of the PEG linker. We closely
followed the procedure developed by the Lyubchenko group, who
repeatedly showed that when treated as noted in our methods and
kept in such a dilute solution, Ab will not aggregate [38,42,43].
Figure 6 shows plausible conformations of Ab dimer with and
without copper assembled from stable Ab(1–42) monomer
structures (Reference [53] and private discussion with A. Rauk).
Each monomer has an internal antiparallel b-sheet between
residues 18–21 and 30–33. The dimers are assembled by
juxtaposition of the self-recognition site residues 18–21 in
antiparallel (A, C) and parallel (B, D) orientation. Both orienta-
tions bring His6, His13 and His14 of each monomer into close
proximity, requiring little reorientation to bind Cu2+ ions (filled
green circles). Figure 6 A and B show plausible assemblies for the
Ab-Ab complexes in antiparallel and parallel conformations
without copper. Figure 6 C and D show two possible structures
for Ab-Cu-Ab in anti-parallel and parallel conformations,
respectively. The variety of possible structures and the strength-
Figure 5. Schematic diagram of Ab dimers with and without copper. Without copper, the most favorable conformation of the Ab dimer
involves an anti-parallel conformation (A). With the addition of copper, Ab adopts a parallel dimer conformation (B) stabilized by the occupied copper
binding sites (C).
doi:10.1371/journal.pone.0059005.g005
Figure 6. Proposed structures of Ab dimers with and without
copper assembled from stable Ab(1–42) monomer structures.
Each monomer has an internal antiparallel b-sheet between residues
18–21 and 30–33. The dimers are assembled by juxtaposition of the
self-recognition site residues 18–21 in antiparallel (A, C) and parallel (B,
D) orientation. Both orientations bring His6, His13 and His14 of each
monomer into close proximity, requiring little reorientation to bind
Cu2+ ions (filled green circles). Structures are courtesy of D. F. Raffa and
A. Rauk, Molecular Dynamics Study of the Beta Amyloid Peptide of
Alzheimer’s Disease and its Divalent Copper Complexes [53], created
using Raswin software.
doi:10.1371/journal.pone.0059005.g006
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ening of each binding event by Cu2+ results in the broad
distribution of unbinding forces we observed in the presence of
Cu2+ ions (Figure 2B).
Our AFM imaging shows that after 6 hours of incubation in the
presence of copper, no amyloid fibrils were found in a significant
amount. Rather, we observed large amorphous structures that
indicate the presence of a copper-dependent Ab aggregation
pathway distinctive from the aggregation pathway without Cu2+
which leads to fibril formation. The dominance of these
amorphous amyloid aggregates in the presence of copper ions is
consistent with previously published images of amyloid aggrega-
tion in the presence of Cu2+ [54,55].
Trace amounts of metal ions have been shown to decrease the
lag time associated with aggregation [34]. Previously, it has been
unclear why only substoichiometric amounts of metal ions were
needed to reduce the lag time, and thus, increase aggregation. We
believe that the reduction of lag time associated with amyloid
aggregation in the presence of copper is a result of the very initial
dimerization process immediately forming an aggregation nucleus
which other peptide can bind onto.
In summary, we demonstrated that unbinding forces of two Ab
peptides without Cu2+ have two distinct force peaks, likely
associated with parallel and anti-parallel configurations, and
resulted in amyloid fibril formations as demonstrated by AFM
imaging. The addition of Cu2+ ions resulted in a shift to higher
force distributions and a higher proportion of unbinding events
occurring in the higher force. As seen by the AFM imaging, this
distinct force profile is correlated with the formation of amorphous
aggregates. We assign this effect of Cu2+ to the strengthening of
binding between two individual Ab peptides and disruption of
fibril formation pathway at a single molecule level.
Conclusions
In conclusion, we report that copper increases peptide-peptide
binding forces at a single molecule level and changes aggregation
observed at the microscale. Therefore, single molecule peptide-
peptide interaction defines a pathway for amyloid aggregation.
This finding leads to a better understanding of the role of
biometals in the mechanism of amyloid fibril formation.
Acknowledgments
The authors would like to thank Prof. Scott Taylor (University
of Waterloo) and his laboratory for synthesis of APS. We also
acknowledge Melesa Hane for the critical reading of the
manuscript and Brenda Yasie Lee for assistance in creating
drawings. Authors greatly appreciate critical discussion of the
manuscript and contributed proposed structures of dimers by Prof.
Arvi Rauk.
Author Contributions
Conceived and designed the experiments: FH ZL. Performed the
experiments: FH GT SA. Analyzed the data: FH SA. Contributed
reagents/materials/analysis tools: ZL. Wrote the paper: FH GT SA ZL.
References
1. Hardy JA, Higgins GA (1992) Alzheimer’s disease: The amyloid cascade
hypothesis. Science 256: 184–185.
2. Antzutkin O, Balbach J, Leapman R, Rizzo N, Reed J, et al. (2000) Multiple
quantum solid-state nmr indicates a parallel, not antiparallel, organization of
beta-sheets in alzheimer’s beta-amyloid fibrils. Proc Natl Acad Sci U S A 97:
13045–13050.
3. Balbach J, Petkova A, Oyler N, Antzutkin O, Gordon D, et al. (2002)
Supramolecular structure in full-length alzheimer’s beta-amyloid fibrils:
Evidence for a parallel beta-sheet organization from solid-state nuclear magnetic
resonance. Biophys J 83: 1205–1216.
4. Petkova A, Yau W, Tycko R (2006) Experimental constraints on quaternary
structure in alzheimer’s beta-amyloid fibrils. Biochemistry (Mosc) 45: 498–512.
5. Rauk A (2009) The chemistry of alzheimer’s disease. Chem Soc Rev 38: 2698–
2715.
6. Arispe N (2004) Architecture of the alzheimer’s a beta p ion channel pore.
J Membr Biol 197: 33–48.
7. Hung YH, Bush AI, Cherny RA (2010) Copper in the brain and alzheimer’s
disease. J Biol Inorg Chem 15: 61–76.
8. Lin H, Bhatia R, Lal R (2001) Amyloid beta protein forms ion channels:
implications for alzheimer’s disease pathophysiology. FASEB J 15: 2433–2444.
9. Necula M, Kayed R, Milton S, Glabe CG (2007) Small molecule inhibitors of
aggregation indicate that amyloid beta oligomerization and fibrillization
pathways are independent and distinct. J Biol Chem 282: 10311–10324.
10. Bertram L, Tanzi RE (2005) The genetic epidemiology of neurodegenerative
disease. J Clin Invest 115: 1449–1457.
11. Bush AI, Tanzi RE (2008) Therapeutics for alzheimer’s disease based on the
metal hypothesis. Neurotherapeutics 5: 421–432.
12. Roy S, Rauk A (2005) Alzheimer’s disease and the ‘absent’ hypothesis:
mechanism for amyloid beta endothelial and neuronal toxicity. Med Hypotheses
65: 123–137.
13. Lynch T, Cherny R, Bush A (2000) Oxidative processes in alzheimer’s disease:
the role of a beta-metal interactions. Exp Gerontol 35: 445–451.
14. Markesbery W, Carney J (1999) Oxidative alterations in alzheimer’s disease.
Brain Pathol 9: 133–146.
15. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, et al. (2000) Inflammation
and alzheimer’s disease. Neurobiol Aging 21: 383–421.
16. Lovell M, Robertson J, Teesdale W, Campbell J, Markesbery W (1998) Copper,
iron and zinc in alzheimer’s disease senile plaques. J Neurol Sci 158: 47–52.
17. Huang X, Cuajungco M, Atwood C, Hartshorn M, Tyndall J, et al. (1999) Cu(ii)
potentiation of alzheimer a beta neurotoxicity - correlation with cell-free
hydrogen peroxide production and metal reduction. J Biol Chem 274: 37111–
37116.
18. Jiang D, Li X, Williams R, Patel S, Men L, et al. (2009) Ternary complexes of
iron, amyloid-beta, and nitrilotriacetic acid: Binding affinities, redox properties,
and relevance to iron-induced oxidative stress in alzheimer’s disease.
Biochemistry (Mosc) 48: 7939–7947.
19. Jomova K, Vondrakova D, Lawson M, Valko M (2010) Metals, oxidative stress
and neurodegenerative disorders. Mol Cell Biochem 345: 91–104.
20. Liu W, Kato M, Akhand A, Hayakawa A, Suzuki H, et al. (2000) 4-
hydroxynonenal induces a cellular redox status-related activation of the caspase
cascade for apoptotic cell death. J Cell Sci 113: 635–641.
21. Sayre L, Perry G, Harris P, Liu Y, Schubert K, et al. (2000) In situ oxidative
catalysis by neurofibrillary tangles and senile plaques in alzheimer’s disease: A
central role for bound transition metals. J Neurochem 74: 270–279.
22. Smith M, Harris P, Sayre L, Perry G (1997) Iron accumulation in alzheimer
disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 94:
9866–9868.
23. Harper J, Lansbury P (1997) Models of amyloid seeding in alzheimier’s disease
and scrapie: Mechanistic truths and physiological consequences of the time-
dependent solubility of amyloid proteins. Annu Rev Biochem 66: 385–407.
24. Sarell CJ, Wilkinson SR, Viles JH (2010) Substoichiometric levels of cu2+ ions
accelerate the kinetics of fiber formation and promote cell toxicity of amyloid-
beta from alzheimer disease. J Biol Chem 285: 41533–41540.
25. Dong J, Atwood C, Anderson V, Siedlak S, Smith M, et al. (2003) Metal binding
and oxidation of amyloid-beta within isolated senile plaque cores: Raman
microscopic evidence. Biochemistry (Mosc) 42: 2768–2773.
26. Faller P, Hureau C (2009) Bioinorganic chemistry of copper and zinc ions
coordinated to amyloid–beta peptide. Dalton Trans: 1080–1094.
27. Miller L, Wang Q, Telivala T, Smith R, Lanzirotti A, et al. (2006) Synchrotron-
based infrared and x-ray imaging shows focalized accumulation of cu and zn co-
localized with beta-amyloid deposits in alzheimer’s disease. J Struct Biol 155:
30–37.
28. Curtain C, Ali F, Smith D, Bush A, Masters C, et al. (2003) Metal ions, ph, and
cholesterol regulate the interactions of alzheimer’s disease amyloid-beta peptide
with membrane lipid. J Biol Chem 278: 2977–2982.
29. Suwalsky M, Bolognin S, Zatta P (2009) Interaction between alzheimer’s
amyloid-beta and amyloid-beta-metal complexes with cell membranes. Journal
Of Alzheimers Disease 17: 81–90.
30. Azimi S, Rauk A (2011) On the involvement of copper binding to the n-terminus
of the amyloid beta peptide of alzheimer’s disease: A computational study.
Int J Alzheimer’s Dis: 1–15.
31. Han D, Wang H, Yang P (2008) Molecular modeling of zinc and copper binding
with alzheimer’s amyloid beta-peptide. Biometals 21: 189–196.
32. Nair NG, Perry G, Smith MA, Reddy VP (2010) Nmr studies of zinc, copper,
and iron binding to histidine, the principal metal ion complexing site of amyloid-
beta peptide. Journal Of Alzheimers Disease 20: 57–66.
Effect of Copper on Amyloid Binging Forces
PLOS ONE | www.plosone.org 7 March 2013 | Volume 8 | Issue 3 | e59005
33. Hewitt N, Rauk A (2009) Mechanism of hydrogen peroxide production by
copper-bound amyloid beta peptide: A theoretical study. J Phys Chem B 113:
1202–1209.
34. Huang X, Atwood C, Moir R, Hartshorn M, Tanzi R, et al. (2004) Trace metal
contamination initiates the apparent auto-aggregation, amyloidosis, and
oligomerization of alzheimer’s a beta peptides. J Biol Inorg Chem 9: 954–960.
35. Hinterdorfer P, Dufrene Y (2006) Detection and localization of single molecular
recognition events using atomic force microscopy. Nat Methods 3: 347–355.
36. Allison D, Hinterdorfer P, Han W (2002) Biomolecular force measurements and
the atomic force microscope. Curr Opin Biotechnol 13: 47–51.
37. Lyubchenko YL, Kim BH, Krasnoslobodtsev AV, Yu J (2010) Nanoimaging for
protein misfolding diseases. Wiley Interdisciplinary Reviews-nanomedicine And
Nanobiotechnology 2: 526–543.
38. Kim BH, Palermo NY, Lovas S, Zaikova T, Keana JFW, et al. (2011) Single-
molecule atomic force microscopy force spectroscopy study of a beta-40
interactions. Biochemistry (Mosc) 50: 5154–5162.
39. Shlyakhtenko L, Gall A, Filonov A, Cerovac Z, Lushnikov A, et al. (2003)
Silatrane-based surface chemistry for immobilization of dna, protein-dna
complexes and other biological materials. Ultramicroscopy 97: 279–287.
40. Hutter J, Bechhoefer J (1993) Calibration of atomic-force microscope tips. Rev
Sci Instrum 64: 1868–1873.
41. Fezoui Y, Hartley D, Harper J, Khurana R, Walsh D, et al. (2000) An improved
method of preparing the amyloid beta-protein for fibrillogenesis and
neurotoxicity experiments. Amyloid-international Journal Of Experimental
And Clinical Investigation 7: 166–178.
42. McAllister C, Karymov M, Kawano Y, Lushnikov A, Mikheikin A, et al. (2005)
Protein interactions and misfolding analyzed by afm force spectroscopy. J Mol
Biol 354: 1028–1042.
43. Yu J, Malkova S, Lyubchenko YL (2008) alpha-synuclein misfolding: Single
molecule afm force spectroscopy study. J Mol Biol 384: 992–1001.
44. He X, Giurleo JT, Talaga DS (2010) Role of small oligomers on the
amyloidogenic aggregation free-energy landscape. J Mol Biol 395: 134–154.
45. Yamaguchi T, Yagi H, Goto Y, Matsuzaki K, Hoshino M (2010) A disulfide-
linked amyloid-beta peptide dimer forms a protofibril-like oligomer through a
distinct pathway from amyloid fibril formation. Biochemistry (Mosc) 49: 7100–
7107.
46. Tjernberg L, Lilliehook C, Callaway D, Naslund J, Hahne S, et al. (1997)
Controlling amyloid beta-peptide fibril formation with protease-stable ligands.
J Biol Chem 272: 12601–12605.
47. Tjernberg L, Naslund J, Lindqvist F, Johansson J, Karlstrom A, et al. (1996)
Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem
271: 8545–8548.
48. Mothana B, Roy S, Rauk A (2009) Molecular dynamics study of the interaction
of a beta(13–23) with beta-sheet inhibitors. ARKIVOC: 116–134.
49. Pedersen JT, Ostergaard J, Rozlosnik N, Gammelgaard B, Heegaard NHH
(2011) Cu(ii) mediates kinetically distinct, non-amyloidogenic aggregation of
amyloid-beta peptides. J Biol Chem 286: 26952–26963.
50. Cote S, Laghaei R, Derreumaux P, Mousseau N (2012) Distinct dimerization for
various alloforms of the amyloid-beta protein: A beta(1–40), a beta(1–42), and a
beta(1–40)(d23n). JOURNAL OF PHYSICAL CHEMISTRY B 116: 4043–
4055.
51. Barz B, Urbanc B (2012) Dimer formation enhances structural differences
between amyloid beta-protein (1–40) and (1–42): An explicit-solvent molecular
dynamics study. PLOS ONE 7.
52. Karacsony O, Akhremitchev BB (2011) On the detection of single bond ruptures
in dynamic force spectroscopy by afm. Langmuir 27: 11287–11291.
53. Raffa DF, Rauk A (2007) Molecular dynamics study of the beta amyloid peptide
of alzheimer’s disease and its divalent copper complexes. J Phys Chem B 111:
3789–3799.
54. Ha C, Ryu J, Park CB (2007) Metal ions differentially influence the aggregation
and deposition of alzheimer’s beta-amyloid on a solid template. Biochemistry
(Mosc) 46: 6118–6125.
55. Innocenti M, Salvietti E, Guidotti M, Casini A, Bellandi S, et al. (2010) Trace
copper(ii) or zinc(ii) ions drastically modify the aggregation behavior of amyloid-
beta(1–42): An afm study. Journal Of Alzheimer’s Disease 19: 1323–1329.
Effect of Copper on Amyloid Binging Forces
PLOS ONE | www.plosone.org 8 March 2013 | Volume 8 | Issue 3 | e59005
